Dartmouth Health Continuing Education for Professionals Home, Department of Surgery Grand Rounds - Responsible Opioid Prescribing After Surgery, 8/6/2021 8:00:00 AM - 8/6/2024 9:00:00 AM, By collaborating with surgery experts with the intent to change practice in the care of surgical patients, participants will be able to describe and identify a variety of treatment plans/procedures for patients and recognize changes in the clinical practice of surgery describing novel transforming medical advances.
Presenters
Jean Y. Liu, MD, MS
Assistant Professor of Surgery, Geisel School of Medicine at Dartmouth
Associate Chief of Surgery, VA Medical Center
Richard J. Barth, MD
Professor of Surgery, Geisel School of Medicine at Dartmouth
Chief, Section of General Surgery Dartmouth-Hitchcock Medical Center
Learning Outcome(s)
At the conclusion of this learning activity, participants will be able to discuss overall responsibility for opioid prescribing; including patient education, number of pills prescribed, and the disposal of unused pills, specifically the Buy Back program at the VAMC.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee role was validated by altering the individual’s control over content about the products or services of the commercial interest by the Activity Director and determined to be free of commercial bias. The Speaker role was validated by independent peer review by the Activity Director and determined to be free of commercial bias. All potential conflict(s) were resolved.
* Richard J. Barth, MD ~ has grant/research support, is a major stockholder and is a patent holder for “Systems and methods for guiding tissue resection” with CairnSurgical, LLC.
* John D. Seigne, MD ~ is a stockholder of Johnson & Johnson.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic References
See presentation for bibliographic sources to allow for further study.
Provider Contact Information
Presenters
Jean Y. Liu, MD, MS
Assistant Professor of Surgery, Geisel School of Medicine at Dartmouth
Associate Chief of Surgery, VA Medical Center
Richard J. Barth, MD
Professor of Surgery, Geisel School of Medicine at Dartmouth
Chief, Section of General Surgery Dartmouth-Hitchcock Medical Center
Learning Outcome(s)
At the conclusion of this learning activity, participants will be able to discuss overall responsibility for opioid prescribing; including patient education, number of pills prescribed, and the disposal of unused pills, specifically the Buy Back program at the VAMC.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control content have reported the following financial interest or relationship* with various companies/organizations. The Planning Committee role was validated by altering the individual’s control over content about the products or services of the commercial interest by the Activity Director and determined to be free of commercial bias. The Speaker role was validated by independent peer review by the Activity Director and determined to be free of commercial bias. All potential conflict(s) were resolved.
* Richard J. Barth, MD ~ has grant/research support, is a major stockholder and is a patent holder for “Systems and methods for guiding tissue resection” with CairnSurgical, LLC.
* John D. Seigne, MD ~ is a stockholder of Johnson & Johnson.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Bibliographic References
See presentation for bibliographic sources to allow for further study.
Provider Contact Information
